EcoDrugPlus

Inositol Polyphosphate-5-Phosphatase D

Ensembl ID : ENSMZEG00005008710
Gene Symbol: INPP5D
3 Cross references
215 Possible Orthologues:

Insulin Like Growth Factor 1 Receptor

Ensembl ID : ENSMZEG00005021278
Gene Symbol: IGF1R
3 Cross references
204 Possible Orthologues:

Insulin Receptor

Ensembl ID : ENSMZEG00005028048
Gene Symbol: LOC101469999
3 Cross references
212 Possible Orthologues:

Insulin Receptor

Ensembl ID : ENSMZEG00005024476
Gene Symbol: LOC101480309
3 Cross references
212 Possible Orthologues:

Insulin-Like Growth Factor 1 Receptor

Ensembl ID : ENSMZEG00005005511
Gene Symbol: LOC101469217
3 Cross references
203 Possible Orthologues:

Integrin Alpha-5

Ensembl ID : ENSMZEG00005026510
Gene Symbol: LOC101480709
3 Cross references
206 Possible Orthologues:

Integrin Beta-1

Ensembl ID : ENSMZEG00005005226
Gene Symbol: LOC101466194
3 Cross references
228 Possible Orthologues:

Integrin Beta-1

Ensembl ID : ENSMZEG00005017220
Gene Symbol: LOC101477057
3 Cross references
213 Possible Orthologues:

Integrin Beta-3

Ensembl ID : ENSMZEG00005022832
Gene Symbol: LOC101467289
3 Cross references
201 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSMZEG00005021478
Gene Symbol: ITGA4
3 Cross references
225 Possible Orthologues:

Integrin Subunit Alpha 5

Ensembl ID : ENSMZEG00005007903
Gene Symbol: ITGA5
3 Cross references
197 Possible Orthologues:

Integrin Subunit Alpha V

Ensembl ID : ENSMZEG00005020249
Gene Symbol: ITGAV
3 Cross references
237 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).